Hjem › Blodcancer › Californien
Blodcancer kliniske forsøg i Californien
35 studier for Blodcancer søger deltagere på steder i Californien.
Byer i Californien
- Los Angeles17 studier
- Baldwin Park13 studier
- San Francisco8 studier
- Orange7 studier
- San Diego6 studier
- Mountain View4 studier
- Sacramento3 studier
- San Bernardino3 studier
Officiel studietekst (engelsk)
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- Comprehensive Blood & Cancer Center [Bakersfield, CA] ( Site 0054), Bakersfield
- UCLA - Hematology/Oncology - Administrative Office ( Site 0009), Los Angeles
- Stanford Cancer Center ( Site 0086), Palo Alto
- og 2 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT03486873Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- PCR Oncology, Arroyo Grande
- AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
- og 20 flere
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- University of California San Diego Moores Cancer Center ( Site 2717), La Jolla
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT04728893Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 1, Duarte
- Quetzal Site 7, Los Angeles
- Quetzal Site 5, Stanford
RekruttererFase 3
Alder 18 til 71 · Alle køn · Opdateret 23. sep. 2026 · NCT07504458Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345Wearable Activity Tracking to Curb Hospitalizations
- University of California, San Francisco, San Francisco
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT06587100Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- UC Irvine, Orange
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT07648264Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- PCR Oncology, Arroyo Grande
- Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank
- Washington Health, Fremont
- og 3 flere
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 17. sep. 2026 · NCT04242095(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- City of Hope Comprehensive Cancer Center, Duarte
- UCLA Medical Center, Los Angeles
- Stanford Cancer Institute, Stanford
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT04996875A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- City of Hope Medical Center, Duarte
- University of California San Diego Medical Center, Moores Cancer Center, La Jolla
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT07195916M-2018-334 in Hematological Malignancies
- City of Hope, Duarte
Rekrutterer
Alder 18 til 75 · Alle køn · Opdateret 11. sep. 2026 · NCT06225050The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
- City of Hope, Duarte
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 12 til 120 · Alle køn · Opdateret 11. sep. 2026 · NCT05436418Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
- City of Hope National Medical Center, Duarte
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT04588922Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy
- City of Hope Medical Center, Duarte
RekruttererFase 3Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 28. aug. 2026 · NCT07186192Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- University of California, Fresno, Clovis
- University of California, San Diego, La Jolla
- Cedars-Sinai Medical Center, Los Angeles
- og 2 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT07007312Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- USC Norris Comprehensive Cancer Center, Los Angeles
- UCLA Health - Bowyer Oncology Center, Los Angeles
- UC Irvine Health Chao Family Comprehensive Cancer Center, Orange
- og 1 flere
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT06001788Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
- Cedars-Sinai Medical Center, Los Angeles
RekruttererFase 1
Alder 18 til 85 · Alle køn · Opdateret 10. aug. 2026 · NCT05887167A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
- City Of Hope, Duarte
- University of California, Los Angeles
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 10. aug. 2026 · NCT06823167Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant
- Cedars-Sinai Medical Center, Los Angeles
RekruttererFase 1
Alder 65 og opefter · Alle køn · Opdateret 5. aug. 2026 · NCT05849207PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
- City of Hope National Medical Center, Duarte
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 4. aug. 2026 · NCT06665100A Study of APG-3288 in Relapsed/Refractory Blood Cancers
- START Los Angele, Los Angeles
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 30. jul. 2026 · NCT07424833Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- UCLA Department of Medicine, Los Angeles
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 7. jul. 2026 · NCT07216443A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- City of Hope, Duarte
- Children's Hospital of Los Angeles, Glendale
- Scripps Green Hospital, La Jolla
- og 8 flere
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 6. jul. 2026 · NCT01351545IVIG for Infection Prevention After CAR-T-Cell Therapy
- City of Hope Cancer Center, Duarte
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 29. jun. 2026 · NCT05952804An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
- University of California LA, Los Angeles
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 11. jun. 2026 · NCT06401356Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- UC San Diego Moores Cancer Center, La Jolla
- University of California, San Francisco, San Francisco
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 1. jun. 2026 · NCT05663502A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
- UCSF Benioff Children's Hospital Oakland, Oakland
- UCSF Medical Center-Mission Bay, San Francisco
RekruttererFase 3
Alder 2 til 18 · Alle køn · Opdateret 5. maj 2026 · NCT05711667CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- City of Hope, Duarte
- Providence St. John's Health Center, Santa Monica
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 16. apr. 2026 · NCT03328078Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
- USC / Norris Comprehensive Cancer Center, Los Angeles
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 19 og opefter · Alle køn · Opdateret 2. apr. 2026 · NCT03207854A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- Moores UC San Diego Cancer Center, La Jolla
- USC / Norris Comprehensive Cancer Center, Los Angeles
- UCLA - Bowyer Oncology Center, Los Angeles
- og 1 flere
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 13. mar. 2026 · NCT05735184Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 2. feb. 2026 · NCT06028828A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
- University of Southern California - Norris Comprehensive Cancer Center, Los Angeles
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 25. jun. 2025 · NCT05768269IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
- Valkyrie Clinical Trials, Los Angeles
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 3. jun. 2025 · NCT06119685Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- City of Hope, Duarte
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 15. apr. 2025 · NCT06462365Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital Los Angeles, Los Angeles
- Children's Hospital Orange County, Orange
- UCSF School of Medicine, San Francisco
RekruttererFase 1
Alder 1 til 21 · Alle køn · Opdateret 6. dec. 2024 · NCT05476770Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.